Pessina Augusto, Gribaldo Laura
Department of Public Health, Microbiology, Virology, University of Milan, Italy.
Curr Med Res Opin. 2006 Nov;22(11):2287-300. doi: 10.1185/030079906X148517.
The origin, function and physiology of totipotent embryonic cells are configured to construct organs and create cross-talk between cells for the biological and neurophysiologic development of organisms. Adult stem cells are involved in regenerating tissues for renewal and damage repair.
Adult stem cells have been isolated from adult tissue, umbilical cord blood and other non-embryonic sources, and can transform into many tissues and cell types in response to pathophysiological stimuli. Clinical applications of adult stem cells and progenitor cells have potential in the regeneration of blood cells, skin, bone, cartilage and heart muscle, and may have potential in degenerative diseases. Multi-pluripotent adult stem cells can change their phenotype in response to trans-differentiation or fusion and their therapeutic potential could include therapies regulated by pharmacological modulation, for example mobilising endogenous stem cells and directing them within a tissue to stimulate regeneration. Adult stem cells could also provide a vehicle for gene therapy, and genetically-engineered human adult stem cells have shown success in treatment of genetic disease.
Deriving embryonic stem cells from early human embryos raises ethical, legal, religious and political questions. The potential uses of stem cells for generating human tissues are the subject of ongoing public debate. Stem cells must be used in standardised and controlled conditions in order to guarantee the best safety conditions for the patients. One critical point will be to verify the risk of tumourigenicity; this issue may be more relevant to embryonic than adult stem cells.
全能胚胎细胞的起源、功能和生理学特性决定了其构建器官以及在细胞间建立相互作用,以促进生物体的生物学和神经生理学发育。成体干细胞参与组织再生,以实现更新和损伤修复。
已从成人组织、脐带血和其他非胚胎来源分离出成体干细胞,这些细胞可在病理生理刺激下转化为多种组织和细胞类型。成体干细胞和祖细胞的临床应用在血细胞、皮肤、骨骼、软骨和心肌再生方面具有潜力,在退行性疾病治疗中也可能具有潜力。多能成体干细胞可通过转分化或融合改变其表型,其治疗潜力可能包括通过药物调节进行治疗,例如动员内源性干细胞并引导它们在组织内发挥作用以刺激再生。成体干细胞还可为基因治疗提供载体,基因工程改造的人类成体干细胞已在治疗遗传疾病方面取得成功。
从人类早期胚胎中获取胚胎干细胞引发了伦理、法律、宗教和政治问题。干细胞用于生成人体组织的潜在用途是当前公众辩论的主题。干细胞必须在标准化和可控的条件下使用,以确保为患者提供最佳的安全条件。一个关键点是要验证致瘤风险;这个问题对于胚胎干细胞可能比成体干细胞更为相关。